Experimental studies in epilepsy: Immunologic and inflammatory mechanisms

Seminars in Pediatric Neurology

Volumn 21, Issue 3, 2014, Pages 197-206

  Legido, Agustín ^a   Katsetos, Christos D ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALUMINUM; ANTISERUM; CYCLOOXYGENASE 2; FRACTALKINE; GANGLIOSIDE GM1; GLUTAMIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PILOCARPINE; TETANUS TOXIN; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ABSENCE; ADAPTIVE IMMUNITY; ARTICLE; BLOOD BRAIN BARRIER; CAPILLARY ENDOTHELIAL CELL; CELL INTERACTION; COMORBIDITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTIC STATE; EPILEPTOGENESIS; EXPERIMENTAL EPILEPSY; GENETIC TRANSCRIPTION; GLIOSIS; HIPPOCAMPUS; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; INTRACTABLE EPILEPSY; LEUKOCYTE MIGRATION; MACROGLIA; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; T LYMPHOCYTE ACTIVATION; TEMPORAL LOBE EPILEPSY;

EID: 84916931473     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2014.10.001     Document Type: Article

References (91)

1. Myers R.D. Handbook of Drug and Chemical Stimulation of the Brain: Behavioral, Pharmacological, and Physiological Aspects 1974, Van Nostrand Reinhold Co, New York.
2. Amor S., Puentes F., Baker D., et al. Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-169.
3. Aronica E., Ravizza T., Zurolo E., et al. Astrocyte immune responses in epilepsy. Glia 2012, 60:1258-1268.
4. Kramer U., Chi C.S., Lin K.L., et al. Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome: A multicenter study on 77 children. Epilepsia 2011, 52:1956-1965.
5. McNaull B.B., Todd S., McGuinness B., et al. Inflammation and anti-inflammatory strategies for Alzheimer's disease-A mini-review. Gerontology 2010, 56:3-14.
6. Schwartz M., Kipnis J. A conceptual revolution in the relationships between the brain and immunity. Brain Behav Immun 2011, 25:817-819.
7. Xanthos D.N., Sandkuhler J. Neurogenic neuroinflammation: Inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci 2014, 15:43-53.
8. Skaper S.D., Facci L. Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide. Philos Trans R Soc Lond B Biol Sci 2012, 367:3312-3325.
9. Skaper S.D., Giusti P., Facci L. Microglia and mast cells: Two tracks on the road to neuroinflammation. FASEB J 2012, 26:3103-3117.
10. Jacobs A.H., Tavitian B. Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab 2012, 32:1393-1415.
11. Wilcox K.S., Vezzani A. Does brain inflammation mediate pathological outcomes in epilepsy?. Adv Exp Med Biol 2014, 813:169-183.
12. Skaper S.D., Facci L., Giusti P. Mast cells, glia and neuroinflammation: Partners in crime?. Immunology 2014, 141:314-327.
13. Abbott N.J., Friedman A. Overview and introduction: The blood-brain barrier in health and disease. Epilepsia 2012, 53:1-6. (suppl 6).
14. Griffiths M.R., Gasque P., Neal J.W. The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J Neuropathol Exp Neurol 2009, 68:217-226.
15. Bailey S.L., Carpentier P.A., McMahon E.J., et al. Innate and adaptive immune responses of the central nervous system. Crit Rev Immunol 2006, 26:149-188.
16. Hickey W.F. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001, 36:118-124.
17. Aloisi F. Immune function of microglia. Glia 2001, 36:165-179.
18. Neumann H. Control of glial immune function by neurons. Glia 2001, 36:191-199.
19. Monier A., Adle-Biassette H., Delezoide A.L., et al. Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex. J Neuropathol Exp Neurol 2007, 66:372-382.
20. Chinnery H.R., Ruitenberg M.J., McMenamin P.G. Novel characterization of monocyte-derived cell populations in the meninges and choroid plexus and their rates of replenishment in bone marrow chimeric mice. J Neuropathol Exp Neurol 2010, 69:896-909.
21. Ziebell J.M., Adelson P.D., Lifshitz J. Microglia: Dismantling and rebuilding circuits after acute neurological injury. Metab Brain Dis 2014, [Epub ahead of print] PMID: 24733573.
22. Ferrini F., De Koninck Y. Microglia control neuronal network excitability via BDNF signalling. Neural Plast 2013, 429815:2014. [Epub ahead of print] PMID 24089642.
23. Ashhab M.U., Omran A., Kong H., et al. Expressions of tumor necrosis factor alpha and microRNA-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy. J Mol Neurosci 2013, 51:950-958.
24. Devinsky O., Vezzani A., Najjar S., et al. Glia and epilepsy: Excitability and inflammation. Trends Neurosci 2013, 36:174-184.
25. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007, 28:138-145.
26. Seifert G., Carmignoto G., Steinhauser C. Astrocyte dysfunction in epilepsy. Brain Res Rev 2010, 63:212-221.
27. Sofroniew M.V., Vinters H.V. Astrocytes: Biology and pathology. Acta Neuropathol 2010, 119:7-35.
28. Aronica E., Crino P.B. Inflammation in epilepsy: Clinical observations. Epilepsia 2011, 52:26-32. (suppl 3).
29. Vezzani A., Balosso S., Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008, 22:797-803.
30. Maroso M., Balosso S., Ravizza T., et al. Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: The importance of IL-1beta and high-mobility group box 1. J Intern Med 2011, 270:319-326.
31. O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 Years of progress. Immunol Rev 2008, 226:10-18.
32. Vezzani A., Aronica E., Mazarati A., et al. Epilepsy and brain inflammation. Exp Neurol 2011, 244:11-21.
33. Vezzani A., French J., Bartfai T., et al. The role of inflammation in epilepsy. Nat Rev Neurol 2011, 7:31-40.
34. Carare R.O., Hawkes C.A., Weller R.O. Afferent and efferent immunological pathways of the brain. Anatomy, function and failure. Brain Behav Immun 2014, 36:9-14.
35. Weller R.O., Galea I., Carare R.O., et al. Pathophysiology of the lymphatic drainage of the central nervous system: Implications for pathogenesis and therapy of multiple sclerosis. Pathophysiology 2010, 17:295-306.
36. Greenwood J., Heasman S.J., Alvarez J.I., et al. Review: Leucocyte-endothelial cell crosstalk at the blood-brain barrier: A prerequisite for successful immune cell entry to the brain. Neuropathol Appl Neurobiol 2011, 37:24-39.
37. Williams K., Alvarez X., Lackner A.A. Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 2001, 36:156-164.
38. Katsetos C.D., Fincke J.E., Legido A., et al. Angiocentric CD3(+) T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children. Clin Diagn Lab Immunol 1999, 6:105-114.
39. Owens T., Bechmann I., Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol 2008, 67:1113-1121.
40. Arjmandi A., Liu K., Dorovini-Zis K. Dendritic cell adhesion to cerebral endothelium: Role of endothelial cell adhesion molecules and their ligands. J Neuropathol Exp Neurol 2009, 68:300-313.
41. Prinz M., Priller J. Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J Neuroimmunol 2010, 224:80-84.
42. Kopeloff N., Kopeloff L.M., Pacella B.L. The experimental production of epilepsy in animals. Proc Annu Meet Am Psychopathol Assoc 1947, 36:163-180.
43. Mihailovic L., Jankovic B.D. Effects of intraventricularly injected anti-n. caudatus antibody on the electrical activity of the cat brain. Nature 1961, 192:665-666.
44. Karpiak S.E., Bowen F.P., Rapport M.M. Epileptiform activity induced by antiserum to synaptic membrane. Brain Res 1973, 59:303-310.
45. Karpiak S.E., Rapport M.M., Bowen F.P. Immunologically induced behavioral and electrophysiological changes in the rat. Neuropsychologia 1974, 12:313-322.
46. Karpiak S.E., Graf L., Rapport M.M. Antiserum to brain gangliosides produces recurrent epileptiform activity. Science 1976, 194:735-737.
47. Karpiak S.E., Huang Y.L., Rapport M.M. Immunological model of epilepsy. Epileptiform activity induced by fragments of antibody to GM1 ganglioside. J Neuroimmunol 1982, 3:15-21.
48. Frieder B., Karpiak S.E., Rapport M.M. Effect of antiepileptic drugs and an anticonvulsant on epileptiform activity induced by antibodies to ganglioside. Exp Neurol 1982, 78:644-653.
49. Frieder B., Rapport M.M. Enhancement of depolarization-induced release of gamma-aminobutyric acid from brain slices by antibodies to ganglioside. J Neurochem 1981, 37:634-639.
50. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995, 37:436-442.
51. Harris A.B. Degeneration in experimental epileptic foci. Arch Neurol 1972, 26:434-449.
52. Cazzullo C.L., Altamura A.C., Canger R., et al. Cobalt-induced experimental epilepsy in cats pharmacologically immunodepressed. An EEG and histological study. Arzneimittelforschung 1976, 26:1387-1393.
53. Shaw J.A., Perry V.H., Mellanby J. MHC class II expression by microglia in tetanus toxin-induced experimental epilepsy in the rat. Neuropathol Appl Neurobiol 1994, 20:392-398.
54. Dambinova S.A., Granstrem O.K., Tourov A., et al. Monitoring of brain spiking activity and autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptors in blood serum of rats with cobalt-induced epilepsy. J Neurochem 1998, 71:2088-2093.
55. Vezzani A., Conti M., De Luigi A., et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures. J Neurosci 1999, 19:5054-5065.
56. Donnelly S., Loscher C., Mills K.H., et al. Glycerol-induced seizure: Involvement of IL-1beta and glutamate. Neuroreport 1999, 10:1821-1825.
57. Jankowsky J.L., Patterson P.H. Differential regulation of cytokine expression following pilocarpine-induced seizure. Exp Neurol 1999, 159:333-346.
58. De Simoni M.G., Perego C., Ravizza T., et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000, 12:2623-2633.
59. Vezzani A., Moneta D., Conti M., et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 2000, 97:11534-11539.
60. Esen N., Ates N., Gurbuz Y., et al. Age dependent changes in some immune system parameters and GFAP immunoreactivity in genetically absence epileptic rats. Int J Neurosci 2001, 109:261-272.
61. Kubera M., Budziszewska B., Basta-Kaiml A., et al. Immunoreactivity in kainate model of epilepsy. Pol J Pharmacol 2001, 53:541-545.
62. During M.J., Symes C.W., Lawlor P.A., et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000, 287:1453-1460.
63. Tuncok Y., Hieda Y., Keyler D.E., et al. Inhibition of nicotine-induced seizures in rats by combining vaccination against nicotine with chronic nicotine infusion. Exp Clin Psychopharmacol 2001, 9:228-234.
64. Voutsinos-Porche B., Koning E., Kaplan H., et al. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol Dis 2004, 17:385-402.
65. Omran A., Peng J., Zhang C., et al. Interleukin-1beta and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia 2012, 53:1215-1224.
66. Pernot F., Heinrich C., Barbier L., et al. Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy. Epilepsia 2011, 52:2315-2325.
67. Ravizza T., Balosso S., Vezzani A. Inflammation and prevention of epileptogenesis. Neurosci Lett 2011, 497:223-230.
68. Aronica E., Fluiter K., Iyer A., et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010, 31:1100-1107.
69. Musto A.E., Samii M. Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy. Epilepsia 2011, 52:551-561.
70. Xu Y., Zeng K., Han Y., et al. Altered expression of CX3CL1 in patients with epilepsy and in a rat model. Am J Pathol 2012, 180:1950-1962.
71. Peng J., Omran A., Ashhab M.U., et al. Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy. J Mol Neurosci 2013, 50:291-297.
72. Zhu S., Tai C., Petkau T.L., et al. Progranulin promotes activation of microglia/macrophage after pilocarpine-induced status epilepticus. Brain Res 2013, 1530:54-65.
73. Maroso M., Balosso S., Ravizza T., et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010, 16:413-419.
74. Iori V., Maroso M., Rizzi M., et al. Receptor for advanced glycation endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis 2013, 58:102-114.
75. Gnatek Y., Zimmerman G., Goll Y., et al. Acetylcholinesterase loosens the brain's cholinergic anti-inflammatory response and promotes epileptogenesis. Front Mol Neurosci 2012, 5:66.
76. Ndode-Ekane X.E., Pitkanen A. Urokinase-type plasminogen activator receptor modulates epileptogenesis in mouse model of temporal lobe epilepsy. Mol Neurobiol 2013, 47:914-937.
77. Nunan R., Sivasathiaseelan H., Khan D., et al. Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release. Glia 2014, 62:1313-1327.
78. Ganor Y., Goldberg-Stern H., Cohen R., et al. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA/2J mice, lower seizure threshold and induce abnormal behavior. Psychoneuroendocrinology 2014, 42:106-117.
79. Nitsch C., Klatzo I. Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents. J Neurol Sci 1983, 59:305-322.
80. Frigerio F., Frasca A., Weissberg I., et al. Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology. Epilepsia 2012, 53:1887-1897.
81. Marchi N., Teng Q., Ghosh C., et al. Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity. Brain Res 2010, 1353:176-186.
82. Janigro D. Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier. Epilepsia 2012, 53:26-34. (suppl 1).
83. Suidan G.L., Dickerson J.W., Chen Y., et al. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J Immunol 2010, 184:1031-1040.
84. Marchi N., Fan Q., Ghosh C., et al. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 2009, 33:171-181.
85. Fabene P.F., Laudanna C., Constantin G. Leukocyte trafficking mechanisms in epilepsy. Mol Immunol 2013, 55:100-104.
86. Rossi B., Angiari S., Zenaro E., et al. Vascular inflammation in central nervous system diseases: Adhesion receptors controlling leukocyte-endothelial interactions. J Leukoc Biol 2011, 89:539-556.
87. Racusen L.C., McCrindle B.W., Christenson M., et al. Cyclosporine lowers seizure threshold in an experimental model of electroshock-induced seizures in Munich-Wistar rats. Life Sci 1990, 46:1021-1026.
88. Silverberg J., Ginsburg D., Orman R., et al. Lymphocyte infiltration of neocortex and hippocampus after a single brief seizure in mice. Brain Behav Immun 2010, 24:263-272.
89. Vezzani A. Epilepsy and inflammation in the brain: Overview and pathophysiology. Epilepsy Curr 2014, 14:3-7.
90. Vezzani A., Friedman A., Dingledine R.J. The role of inflammation in epileptogenesis. Neuropharmacology 2013, 69:16-24.
91. Vezzani A., Aronica E., Mazarati A., et al. Epilepsy and brain inflammation. Exp Neurol 2013, 244:11-21.